• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺纤维化患者围手术期危险因素:一项历史性队列研究。

Perioperative risk factors in patients with idiopathic pulmonary fibrosis: a historical cohort study.

作者信息

McDowell Brittany J, Karamchandani Kunal, Lehman Erik B, Conboy Matthew J, Carr Zyad J

机构信息

Department of Anesthesiology & Perioperative Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.

Penn State University College of Medicine, Hershey, PA, USA.

出版信息

Can J Anaesth. 2021 Jan;68(1):81-91. doi: 10.1007/s12630-020-01828-9. Epub 2020 Oct 8.

DOI:10.1007/s12630-020-01828-9
PMID:33029686
Abstract

PURPOSE

Perioperative complications of patients with idiopathic pulmonary fibrosis (IPF) are not well described. The aim of this study was to identify risk factors associated with adverse postoperative outcomes in IPF patients.

METHODS

We performed a single-centre historical cohort study of adult patients with IPF who underwent surgery between 2008 and 2018. We analyzed the prognostic utility of select perioperative factors for postoperative acute exacerbation of IPF (AE-IPF), acute respiratory worsening (ARW), pneumonia, and 30-day and one-year mortality using univariable and multivariable regression analyses. To adjust for multiple interactions, the false discovery rate (Q value) was utilized to appropriately adjust P values and a Q value < 0.05 was considered to be significant.

RESULTS

Two hundred and eighty-two patients were identified. After excluding emergency cases and bronchoscopies performed for active pneumonia, 14.2% of the cohort developed ARW that persisted > 24 hr after surgery, 5.0% had AE-IPF, and 9.2% were diagnosed with postoperative pneumonia within 30 days of surgery. The 30-day mortality was 6.0% and the one-year mortality was 14.9%. Preoperative home oxygen use (relative risk [RR], 2.70; 95% confidence interval [CI], 1.50 to 4.86; P < 0.001) and increasing surgical time (per 60 min) (RR, 1.03; 95% CI, 1.02 to 1.05; P < 0.001) were identified as independent risk factors for postoperative ARW.

CONCLUSIONS

In IPF patients, preoperative home oxygen requirement and increasing surgical time showed a strong relationship with postoperative ARW and may be useful markers for perioperative risk stratification. Facteurs de risque périopératoires des patients atteints de fibrose pulmonaire idiopathique : une étude de cohorte historique.

摘要

目的

特发性肺纤维化(IPF)患者围手术期并发症的情况尚未得到充分描述。本研究的目的是确定与IPF患者术后不良结局相关的危险因素。

方法

我们对2008年至2018年间接受手术的成年IPF患者进行了一项单中心历史队列研究。我们使用单变量和多变量回归分析,分析了选定围手术期因素对IPF术后急性加重(AE-IPF)、急性呼吸恶化(ARW)、肺炎以及30天和1年死亡率的预后效用。为了调整多重相互作用,采用错误发现率(Q值)来适当调整P值,Q值<0.05被认为具有统计学意义。

结果

共纳入282例患者。排除急诊病例和因活动性肺炎进行的支气管镜检查后,14.2%的队列患者术后发生持续>24小时的ARW,5.0%发生AE-IPF,9.2%在术后30天内被诊断为术后肺炎。30天死亡率为6.0%,1年死亡率为14.9%。术前家庭氧疗(相对风险[RR],2.70;95%置信区间[CI],1.50至4.86;P<0.001)和手术时间延长(每60分钟)(RR,1.03;95%CI,1.02至1.05;P<0.001)被确定为术后ARW的独立危险因素。

结论

在IPF患者中,术前家庭氧需求和手术时间延长与术后ARW密切相关,可能是围手术期风险分层的有用指标。特发性肺纤维化患者的围手术期危险因素:一项历史队列研究。

相似文献

1
Perioperative risk factors in patients with idiopathic pulmonary fibrosis: a historical cohort study.特发性肺纤维化患者围手术期危险因素:一项历史性队列研究。
Can J Anaesth. 2021 Jan;68(1):81-91. doi: 10.1007/s12630-020-01828-9. Epub 2020 Oct 8.
2
Patients With Fibrotic Interstitial Lung Disease Hospitalized for Acute Respiratory Worsening: A Large Cohort Analysis.因急性呼吸功能恶化住院的纤维化间质性肺疾病患者:一项大型队列分析。
Chest. 2016 May;149(5):1205-14. doi: 10.1016/j.chest.2015.12.026. Epub 2016 Jan 11.
3
A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).一项评估围手术期使用吡非尼酮预防接受肺切除术的肺癌患者特发性肺纤维化急性加重的疗效和安全性的II期试验:日本西部肿瘤学组6711L(PEOPLE研究)。
Respir Res. 2016 Jul 22;17(1):90. doi: 10.1186/s12931-016-0398-4.
4
Experience with perioperative pirfenidone for lung cancer surgery in patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者围手术期使用吡非尼酮进行肺癌手术的经验。
Surg Today. 2015 Oct;45(10):1263-70. doi: 10.1007/s00595-014-1071-5. Epub 2014 Nov 22.
5
Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.血栓调节蛋白对特发性肺纤维化和非特异性间质性肺炎急性加重期的疗效:一项非随机前瞻性研究。
Drug Des Devel Ther. 2015 Oct 23;9:5755-62. doi: 10.2147/DDDT.S90739. eCollection 2015.
6
Perioperative Management of Patients with Idiopathic Pulmonary Fibrosis Undergoing Noncardiac Surgery: A Narrative Review.特发性肺纤维化患者非心脏手术的围手术期管理:一项叙述性综述
Int J Gen Med. 2022 Feb 23;15:2087-2100. doi: 10.2147/IJGM.S266217. eCollection 2022.
7
Perioperative pirfenidone treatment as prophylaxis against acute exacerbation of idiopathic pulmonary fibrosis: a single-center analysis.围手术期使用吡非尼酮预防特发性肺纤维化急性加重:单中心分析
Surg Today. 2020 Aug;50(8):905-911. doi: 10.1007/s00595-020-01978-9. Epub 2020 Mar 6.
8
Prognostic evaluation by oxygenation with positive end-expiratory pressure in acute exacerbation of idiopathic pulmonary fibrosis: A retrospective cohort study.呼气末正压通气氧合对特发性肺纤维化急性加重期的预后评估:一项回顾性队列研究
Clin Respir J. 2018 Mar;12(3):895-903. doi: 10.1111/crj.12602. Epub 2017 Jan 12.
9
The incidence of acute exacerbation of idiopathic pulmonary fibrosis: a systematic review and meta-analysis.特发性肺纤维化急性加重的发生率:系统评价和荟萃分析。
Sci Rep. 2024 Sep 10;14(1):21080. doi: 10.1038/s41598-024-71845-x.
10
Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis.围手术期使用吡非尼酮治疗对合并特发性肺纤维化的肺癌患者的影响。
Ann Thorac Surg. 2016 Dec;102(6):1905-1910. doi: 10.1016/j.athoracsur.2016.05.094. Epub 2016 Aug 18.

引用本文的文献

1
Treatment Options for Early Stage Inoperable Breast Cancer: Cryoablation or Radiotherapy?早期不可手术乳腺癌的治疗选择:冷冻消融还是放射治疗?
Breast Care (Basel). 2024 Apr;19(2):106-115. doi: 10.1159/000536413. Epub 2024 Jan 22.
2
LTSI Consensus Guidelines: Preoperative Pulmonary Evaluation in Adult Liver Transplant Recipients.LTSI 共识指南:成人肝移植受者的术前肺部评估
J Clin Exp Hepatol. 2023 May-Jun;13(3):523-531. doi: 10.1016/j.jceh.2022.12.012. Epub 2022 Dec 26.
3
Perioperative Management of Patients with Idiopathic Pulmonary Fibrosis Undergoing Noncardiac Surgery: A Narrative Review.

本文引用的文献

1
Clinical course and management of idiopathic pulmonary fibrosis.特发性肺纤维化的临床病程与管理
Multidiscip Respir Med. 2019 Dec 2;14:35. doi: 10.1186/s40248-019-0197-0. eCollection 2019.
2
Evaluating disease severity in idiopathic pulmonary fibrosis.评估特发性肺纤维化的疾病严重程度。
Eur Respir Rev. 2017 Sep 6;26(145). doi: 10.1183/16000617.0051-2017. Print 2017 Sep 30.
3
Supplemental oxygen and dypsnoea in interstitial lung disease: absence of evidence is not evidence of absence.补充氧气和间质性肺疾病中的呼吸困难:没有证据并不等于不存在证据。
特发性肺纤维化患者非心脏手术的围手术期管理:一项叙述性综述
Int J Gen Med. 2022 Feb 23;15:2087-2100. doi: 10.2147/IJGM.S266217. eCollection 2022.
Eur Respir Rev. 2017 Aug 9;26(145). doi: 10.1183/16000617.0072-2017. Print 2017 Sep 30.
4
The Incidence of Postoperative Pneumonia in Various Surgical Subspecialties: A Dual Database Analysis.各外科亚专业术后肺炎的发病率:双数据库分析
Surg Technol Int. 2017 Jul 25;30:45-51.
5
Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial.纤维化肺病患者的门诊吸氧(AmbOx):一项随机对照试验的研究方案
Trials. 2017 Apr 28;18(1):201. doi: 10.1186/s13063-017-1912-9.